Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Beginning Cash Balance (2019 - 2021)

Marimed (MRMD) has disclosed Beginning Cash Balance for 3 consecutive years, with $185.0 as the latest value for Q2 2021.

  • Quarterly Beginning Cash Balance rose 100.1% to $185.0 in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Sep 2021, down 93.69% year-over-year, with the annual reading at $20.8 million for FY2019, N/A changed from the prior year.
  • Beginning Cash Balance for Q2 2021 was $185.0 at Marimed, down from $1.2 million in the prior quarter.
  • The five-year high for Beginning Cash Balance was $20.6 million in Q4 2019, with the low at -$177143.0 in Q2 2020.
  • Average Beginning Cash Balance over 3 years is $3.7 million, with a median of $199424.0 recorded in 2020.
  • Peak annual rise in Beginning Cash Balance hit 381.33% in 2021, while the deepest fall reached 100.1% in 2021.
  • Over 3 years, Beginning Cash Balance stood at $20.6 million in 2019, then crashed by 99.23% to $158301.0 in 2020, then tumbled by 99.88% to $185.0 in 2021.
  • According to Business Quant data, Beginning Cash Balance over the past three periods came in at $185.0, $1.2 million, and $158301.0 for Q2 2021, Q1 2021, and Q3 2020 respectively.